SMS Pharmaceuticals Limited

NSE SMSPHARMA.NS

SMS Pharmaceuticals Limited Free Cash Flow Yield on February 06, 2025: -0.12%

SMS Pharmaceuticals Limited Free Cash Flow Yield is -0.12% on February 06, 2025, a 82.79% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

SMS Pharmaceuticals Limited 52-week high Free Cash Flow Yield is -0.06% on October 01, 2024, which is 45.30% above the current Free Cash Flow Yield.
SMS Pharmaceuticals Limited 52-week low Free Cash Flow Yield is -0.68% on February 08, 2024, which is -481.20% below the current Free Cash Flow Yield.
SMS Pharmaceuticals Limited average Free Cash Flow Yield for the last 52 weeks is -0.16%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: SMSPHARMA.NS

SMS Pharmaceuticals Limited

CEO	Mr. Ramesh Babu Potluri
IPO Date	Feb. 28, 2007
Location	India
Headquarters	Plot No. 72
Employees	1,197
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Key trends

Past 5 years